ABVX

#4743
Abivax SA American Depositary Shares
121.28
+1.95%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
121.28
121.28
Yıllık aralık
4.77
148.83
Günlük değişim
+1.95%
Aylık değişim
+2.15%
6 aylık değişim
+54.14%
Yıllık değişim
+1532.30%
Önceki kapanış
118.96
Open
121.28
Bid
Ask
Low
121.28
High
121.28
Hacim
43
Open full chart

Financials

Overview Rapor Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24 TTM

Abivax SA - American Depositary Shares

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France.

Haberler